Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

[History of chronic myeloid leukemia: a paradigm in the treatment of cancer].

Gonon-Demoulian R, Goldman JM, Nicolini FE.

Bull Cancer. 2014 Jan 1;101(1):56-67. doi: 10.1684/bdc.2013.1876. French.

PMID:
24491668
[PubMed - indexed for MEDLINE]
2.

Biological therapy and the immune system in patients with chronic myeloid leukemia.

Rohon P.

Int J Hematol. 2012 Jul;96(1):1-9. doi: 10.1007/s12185-012-1116-8. Epub 2012 Jun 4. Review.

PMID:
22661045
[PubMed - indexed for MEDLINE]
3.

Unraveling the genetic underpinnings of myeloproliferative neoplasms and understanding their effect on disease course and response to therapy: proceedings from the 6th International Post-ASH Symposium.

Abdel-Wahab O, Pardanani A, Bernard OA, Finazzi G, Crispino JD, Gisslinger H, Kralovics R, Odenike O, Bhalla K, Gupta V, Barosi G, Gotlib J, Guglielmelli P, Kiladjian JJ, Noel P, Cazzola M, Vannucchi AM, Hoffman R, Barbui T, Thiele J, Van Etten RA, Mughal T, Tefferi A.

Am J Hematol. 2012 May;87(5):562-8. doi: 10.1002/ajh.23169. Epub 2012 Mar 28.

PMID:
22460584
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Long-term follow-up of patients with chronic myeloid leukemia having received autologous stem cell transplantation.

Hackanson B, Waller CF.

Ann Hematol. 2011 Apr;90(4):395-9. doi: 10.1007/s00277-010-1094-y. Epub 2010 Oct 5.

PMID:
20922524
[PubMed - indexed for MEDLINE]
5.

Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.

Gutman JA, Turtle CJ, Manley TJ, Heimfeld S, Bernstein ID, Riddell SR, Delaney C.

Blood. 2010 Jan 28;115(4):757-65. doi: 10.1182/blood-2009-07-228999. Epub 2009 Oct 12.

PMID:
19822900
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

[Chronic myeloid leukemia in the 21st century: biology and treatment].

Chávez-González MA, Ayala-Sánchez M, Mayani H.

Rev Invest Clin. 2009 May-Jun;61(3):221-32. Review. Spanish.

PMID:
19736811
[PubMed - indexed for MEDLINE]
7.

Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation.

Beatty GL, Smith JS, Reshef R, Patel KP, Colligon TA, Vance BA, Frey NV, Johnson FB, Porter DL, Vonderheide RH.

Clin Cancer Res. 2009 Aug 1;15(15):4944-53. doi: 10.1158/1078-0432.CCR-08-3332. Epub 2009 Jul 14.

PMID:
19602548
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Efficient activation of LRH-1-specific CD8+ T-cell responses from transplanted leukemia patients by stimulation with P2X5 mRNA-electroporated dendritic cells.

Overes IM, Fredrix H, Kester MG, Falkenburg JH, van der Voort R, de Witte TM, Dolstra H.

J Immunother. 2009 Jul-Aug;32(6):539-51. doi: 10.1097/CJI.0b013e3181987c22.

PMID:
19483655
[PubMed - indexed for MEDLINE]
9.

Immunotherapy in chronic myelogenous leukemia.

Guilhot F, Roy L, Martineua G, Guilhot J, Millot F.

Clin Lymphoma Myeloma. 2007 Mar;7 Suppl 2:S64-70. Review.

PMID:
17382015
[PubMed - indexed for MEDLINE]
10.

Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.

Olsson-Strömberg U, Höglund M, Björkholm M, Braide I, Carlson K, Gahrton G, Grimfors G, Hast R, Lerner R, Linder O, Ljungman P, Löfvenberg E, Malm C, Nilsson PG, Paul C, Rödjer S, Stenke L, Tidefeldt U, Turesson I, Uden AM, Wahlin A, Vilen L, Winqvist I, Zettervall O, Oberg G, Simonsson B.

Leuk Lymphoma. 2006 Sep;47(9):1768-73.

PMID:
17064986
[PubMed - indexed for MEDLINE]
11.

Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.

Matsushita M, Yamazaki R, Ikeda H, Mori T, Sumimoto H, Fujita T, Okamoto S, Ikeda Y, Kawakami Y.

Br J Haematol. 2006 Jan;132(1):56-65.

PMID:
16371020
[PubMed - indexed for MEDLINE]
12.

A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.

de Rijke B, van Horssen-Zoetbrood A, Beekman JM, Otterud B, Maas F, Woestenenk R, Kester M, Leppert M, Schattenberg AV, de Witte T, van de Wiel-van Kemenade E, Dolstra H.

J Clin Invest. 2005 Dec;115(12):3506-16.

PMID:
16322791
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Chronic myelogenous leukemia.

O'Brien S, Berman E, Bhalla K, Copelan EA, Devetten MP, Emanuel PD, Erba HP, Greenberg PL, Moore JO, Przepiorka D, Radich JP, Schilder RJ, Shami P, Smith BD, Snyder DS, Soiffer RJ, Tallman MS, Talpaz M, Wetzler M.

J Natl Compr Canc Netw. 2005 Nov;3(6):732-55. No abstract available.

PMID:
16316611
[PubMed - indexed for MEDLINE]
14.

New targeted approaches in chronic myeloid leukemia.

Cortes J, Kantarjian H.

J Clin Oncol. 2005 Sep 10;23(26):6316-24. Review. Erratum in: J Clin Oncol. 2005 Dec 10;23(35):9034.

PMID:
16155014
[PubMed - indexed for MEDLINE]
15.

Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures.

Chávez-González A, Ayala-Sánchez M, Sánchez-Valle E, Ruiz-Sánchez E, Arana-Trejo RM, Vela-Ojeda J, Mayani H.

Leuk Res. 2006 Mar;30(3):286-95. Epub 2005 Aug 18.

PMID:
16111748
[PubMed - indexed for MEDLINE]
16.

Intensive treatment and stem cell transplantation in chronic myelogenous leukemia: long-term follow-up.

Simonsson B, Oberg G, Bjoreman M, Bjorkholm M, Carneskog J, Karlsson K, Gahrton G, Grimfors G, Hast R, Karle H, Linder O, Ljungman P, Nielsen JL, Nilsson J, Lofvenberg E, Malm C, Olsson K, Olsson-Stromberg U, Paul C, Stenke L, Stentoft J, Turesson I, Udén AM, Wahlin A, Vilén L, Weis-Bjerrum O.

Acta Haematol. 2005;113(3):155-62.

PMID:
15870485
[PubMed - indexed for MEDLINE]
17.

Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.

Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.

Biol Blood Marrow Transplant. 2004 Mar;10(3):204-12.

PMID:
14993886
[PubMed - indexed for MEDLINE]
18.

Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.

Sillaber C, Mayerhofer M, Agis H, Sagaster V, Mannhalter C, Sperr WR, Geissler K, Valent P.

Wien Klin Wochenschr. 2003 Aug 14;115(13-14):485-504. Review.

PMID:
13677268
[PubMed - indexed for MEDLINE]
19.

Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administration.

Hájek R, Zácková D, Büchler T, Penka M, Krahulcová E, Korístek Z, Vinklárková J, Adler J, Janovská E, Indrák K, Faber E, Doubek M, Klabusay M, Oltová A, Kuglík P, Bourková L, Dusek L, Mareschová I, Mayer J, Vorlícek J.

Med Oncol. 2003;20(1):69-76.

PMID:
12665687
[PubMed - indexed for MEDLINE]
20.

The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model.

Ren R.

Oncogene. 2002 Dec 9;21(56):8629-42. Review.

PMID:
12476309
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk